Verano Holdings (VRNO) Free Cash Flow Growth (1y) (2022 - 2026)
Verano Holdings (VRNO) Free Cash Flow Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 134.35% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 17.21% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -37.45% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 58.76% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 97.24% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 43.69% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 35.56% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Verano Holdings | 433.71 Mn | 348.51 Mn | 99.70 Mn | 4,251.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4,251.28% |
| Mar 31, 2026 | 130.22% |
| Dec 31, 2025 | -85.03% |
| Sep 30, 2025 | 170.36% |
| Jun 30, 2025 | 104.07% |
| Mar 31, 2025 | -156.59% |
| Dec 31, 2024 | -45.76% |
| Sep 30, 2024 | -200.74% |
| Jun 30, 2024 | -166.67% |
| Mar 31, 2024 | 156.92% |
| Dec 31, 2023 | -59.37% |
| Sep 30, 2023 | 131.45% |
| Jun 30, 2023 | -70.68% |
| Mar 31, 2023 | 160.01% |
| Dec 31, 2022 | 869.39% |
| Sep 30, 2022 | -358.00% |